Categories: AntibioticsBiotechnologyDrugDiscoveryInfectiousDiseasesPharma
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.07.2025 | - | $2.7M | CARB-X |
Mentions in press and media 2
| Date | Title | Description |
| 29.07.2025 | Kinvard Bio Receives Follow-on CARB-X Funding | Kinvard Bio Inc., a Raleigh, NC-based biotechnology company providing a new class of broad-spectrum antibiotics, received US$2.7M follow-on non-dilutive funding from CARB-X.
The company intends to use the funds to accelerate the advancement... |
| - | Kinvard Bio | - |
Reviews 0